Expression of a retinoic acid receptor gene in myeloid leukemia cells - PubMed (original) (raw)

Affiliations

PMID: 2538684

Expression of a retinoic acid receptor gene in myeloid leukemia cells

C Wang et al. Leukemia. 1989 Apr.

Abstract

Retinoic acid (RA) has been shown to increase differentiation in some leukemia cell lines (HL-60 and KG-1) but not others (K562). Similarly, RA has been reported to have variable effects on fresh blast cells. Recently, molecular clones have been obtained for the nuclear receptor for retinoic acid. The experiments described in this paper were designed to compare expression of the receptor to biological activity in myeloblastic leukemia cells. In four continuous AML cell lines, a positive correlation was found between retinoic acid receptor (RAR) expression by Northern analysis or RNA dot blot and the ability of RA to inhibit colony formation. Kinetic studies of the most sensitive cell line showed that inhibition of colony formation was associated with reduced blast cell self-renewal and differentiation-like events. RAR was detected in freshly obtained blast cells from 23 AML patients. Patient-to-patient variation was observed; however, a correlation was not found between RAR expression and response of the freshly obtained blast cells to RA.

PubMed Disclaimer

Cited by

A tubulin binding molecule drives differentiation of acute myeloid leukemia cells.
Jackson TR, Vuorinen A, Josa-Culleré L, Madden KS, Conole D, Cogswell TJ, Wilkinson IVL, Kettyle LM, Zhang D, O'Mahony A, Gracias D, McCall L, Westwood R, Terstappen GC, Davies SG, Tate EW, Wynne GM, Vyas P, Russell AJ, Milne TA. Jackson TR, et al. iScience. 2022 Jul 19;25(8):104787. doi: 10.1016/j.isci.2022.104787. eCollection 2022 Aug 19. iScience. 2022. PMID: 35992086 Free PMC article.
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates.
Staquicini DI, D'Angelo S, Ferrara F, Karjalainen K, Sharma G, Smith TL, Tarleton CA, Jaalouk DE, Kuniyasu A, Baze WB, Chaffee BK, Hanley PW, Barnhart KF, Koivunen E, Marchiò S, Sidman RL, Cortes JE, Kantarjian HM, Arap W, Pasqualini R. Staquicini DI, et al. Pharmacogenomics J. 2018 May 22;18(3):436-443. doi: 10.1038/tpj.2017.46. Epub 2017 Dec 5. Pharmacogenomics J. 2018. PMID: 29205207 Free PMC article.
A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity.
Jitkova Y, Gronda M, Hurren R, Wang X, Goard CA, Jhas B, Schimmer AD. Jitkova Y, et al. PLoS One. 2014 May 28;9(5):e95281. doi: 10.1371/journal.pone.0095281. eCollection 2014. PLoS One. 2014. PMID: 24871339 Free PMC article.
Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.
Gañán-Gómez I, Wei Y, Yang H, Pierce S, Bueso-Ramos C, Calin G, Boyano-Adánez Mdel C, García-Manero G. Gañán-Gómez I, et al. PLoS One. 2014 Apr 1;9(4):e93404. doi: 10.1371/journal.pone.0093404. eCollection 2014. PLoS One. 2014. PMID: 24690917 Free PMC article.
Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism.
Mourtada R, Fonseca SB, Wisnovsky SP, Pereira MP, Wang X, Hurren R, Parfitt J, Larsen L, Smith RA, Murphy MP, Schimmer AD, Kelley SO. Mourtada R, et al. PLoS One. 2013 Apr 9;8(4):e60253. doi: 10.1371/journal.pone.0060253. Print 2013. PLoS One. 2013. PMID: 23585833 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations
Medical
- MedlinePlus Health Information
Research Materials
- Cellosaurus - a cell line knowledge resource
- NCI CPTC Antibody Characterization Program

Expression of a retinoic acid receptor gene in myeloid leukemia cells - PubMed (original) (raw)